Via Bonanno, 6
Tel ++39 050 2219595
Fax ++39 050 2210680
Tiziano Tuccinardi was born in Pisa in November 1977.
He graduated in C.T.F (Pharmaceutical chemistry and technologies, a five-year degree course) at the Faculty of Pharmacy of the University of Pisa in 2002 (Marks: 110/110 cum laude) and he obtained the PhD degree in Medicinal Chemistry from the same University in 2006.
From December 2007 to March 2015 he was appointed Assistant Professor at the Faculty of Pharmacy of the University of Pisa.
In 2009 he spent 5 months as Visiting Researcher at the Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
From November 2009 to July 2014 he was appointed Adjunct Assistant Professor at the Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, PA, USA.
Since April 2015 he is Associate Professor of Medicinal Chemistry at the Department of Pharmacy of the University of Pisa.
Since July 2016 he is Adjunct Associate Professor at the Department of Biology, Temple University’s College of Science and Technology, Philadelphia, PA, USA.
In April 2017 he received the National Scientific Qualification for the role of Full Professor (3/D1 sector).
From November 2018 he is the Director of the “Pharmaceutical Chemistry and Technology” MD (long cycle) programme, University of Pisa (click here).
He has published more than 140 papers with an H-index of 29 and more than 2400 citations.
In 2010, he was awarded with the ‘Farmindustria Prize for Pharmaceutical Research’, which is a national award dedicated to scientists younger than 40 years old. Since 2009, he has been a member of the Department for the PhD course “Science of Drug and Bioactive Substances”.
He is co-invetor of four patents and he is a Scientific Advisory Board Member of the Bio Future Medicine (BFM) startup.
He is a member of the Editorial Advisory Board of the following journals: Journal of Enzyme Inhibition & Medicinal Chemistry, Molecules (Medicinal Chemistry section), Current Bioactive Compounds, Drug Development and Therapeutics, Open Journal of Medicinal Chemistry.
His research interests include drug and lead discovery, with a focus on computer-assisted approaches and medicinal chemistry, including synthesis of small molecules, virtual and biomolecular screening.